DP
Diadema Partners Portfolio holdings
AUM
$161M
This Quarter Return
+3.6%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$88.7M
AUM Growth
–
Cap. Flow
+$88.7M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
58.9%
Holding
86
New
54
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$9.05M |
| 2 |
AbbVie
ABBV
|
$8.89M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$6.68M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$5.6M |
| 5 |
Rhythm Pharmaceuticals
RYTM
|
$4.2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
uniQure
QURE
$940M
| – | – |
0
| – | – |
|
77
Ultragenyx Pharmaceutical
RARE
$3.01B
| – | – |
0
| – | – |
|
78
Recursion Pharmaceuticals
RXRX
$1.96B
| – | – |
0
| – | – |
|
79
Cassava Sciences
SAVA
$104M
| – | – |
0
| – | – |
|
80
Summit Therapeutics
SMMT
$17.4B
| – | – |
0
| – | – |
|
81
ARS Pharmaceuticals
SPRY
$1.05B
| – | – |
0
| – | – |
|
82
Vir Biotechnology
VIR
$739M
| – | – |
0
| – | – |
|
|
WAVE
83
Eco Wave Power Global
WAVE
$49M
| – | – |
0
| – | – |
|
84
SPDR S&P Biotech ETF
XBI
$5.25B
| – | – |
0
| – | – |
|
|
ITCI
85
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
0
| – | – |
|
86
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
0
| – | – |
|